Data / Form D filings / Rebiotix Inc.
Rebiotix Inc.: Form D filings
Rebiotix Inc., a biotechnology company in Roseville, MN, filed 3 Form D notices with the SEC between 2011 and 2017. The latest, on September 5, 2017, reports $8.5 million sold of a $10 million offering to 29 investors.
Find out what Rebiotix Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2660 Patton Road, Roseville, MN, 55113
- Phone
- (651) 705-8772
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1532997
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 5, 2017 | New notice | $10,000,000 | $8,515,000 | $1,485,000 | 29 | Aug 24, 2017 | sec.gov |
| Jul 7, 2014 | New notice | $25,000,000 | $18,000,000 | $7,000,000 | 6 | Jun 25, 2014 | sec.gov |
| Nov 4, 2011 | New notice | $5,000,000 | $2,780,000 | $2,220,000 | 28 | Nov 1, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Berman | Director | |
| William McGuire | Director | |
| Greg Fluet | Executive Officer | |
| Lee Jones | Executive Officer, Director | |
| Erwin Kelen | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Sep 4, 2017 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rebiotix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.